Seroprevalence of HBsAg in Patients with Chronic Liver Disease and Hepatocellular Carcinoma at the Earliest Endpoint of treatment: A Cross-Sectional Study Seroprevalence of HBsAg in Patients with Chronic Liver Disease and Hepatocellular Carcinoma

Autor: Mbaga, Donatien Serge, Bikoï, Jacky Njiki, Okobalemba, Etienne Atenguena, Essindi, Justin Olivier, Mikangue, Chris André Mbongue, Touangnou-Chamda, Sabine Aimée, Membangbi, Alexandra Emmanuelle, Ngoutane, Aicha, Elan, Arnaud Franck, Sake, Carole Stéphanie, Essama, Sara Honorine Riwom, Mondinde, George Ikomey, Kenmoe, Sebastien

Background: The ideal goal of therapy of Hepatitis B virus (HBV) infection should be host sterilization which corresponding to clearance of HBsAg from serum and of covalently closed circular DNA (cccDNA) from hepatocytes. Good combination of actual t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05e9605100083871e1abac044992c5e5

Seroprevalence of hepatitis C virus antigen in patients with chronic liver disease and hepatocellular carcinoma at 12^th week of treatment: a cross-sectional study.

Autor: Mbaga, Donatien Serge, Bikoï, Jacky Njiki, Okobalemba, Etienne Atenguena, Essindi, Justin Olivier, Mikangue, Chris André Mbongue, Membangbi, Alexandra Emmanuelle, Ngoutane, Aïcha, Elang, Arnaud Franck, Touangnou-Chamda, Sabine Aimée, Sake, Carole Stéphanie, Mondinde, George Ikomey, Kenmoe, Sebastien, Essama, Sara Honorine Riwom

Publikováno v: Pan African Medical Journal; Sep-Dec2022, Vol. 43, p1-12, 12p

Seroprevalence of Epstein-Barr virus, hepatitis B virus, hepatitis C virus, and human immunodeficiency virus among patients with non-Hodgkin's lymphoma at the Yaounde General Hospital, Cameroon.

Autor: Bikoï, Jacky Njiki, Ndedi, Esther Del Florence Moni, Okobalemba, Etienne Atenguena, Mbaga, Donatien Serge, Mikangue, Chris André Mbongue, Membangbi, Alexandra Emmanuelle, Nguiffo, Elsa Makue, Essindi, Justin Olivier, Mondinde, George Ikomey, Essama, Sara Honorine Riwom

Publikováno v: Pan African Medical Journal; May-Aug2022, Vol. 42, p1-6, 6p

Seroprevalence of hepatitis C virus antigen in patients with chronic liver disease and hepatocellular carcinoma at 12 ^th week of treatment: a cross-sectional study.

Autor: Mbaga DS; Department of Microbiology, The University of Yaoundé I, Yaoundé, Cameroon., Bikoï JN; Department of Microbiology, The University of Yaoundé I, Yaoundé, Cameroon., Okobalemba EA; Faculty of Medicine and Biomedical Sciences, The University of Yaoundé I, Yaoundé, Cameroon., Essindi JO; Department of Microbiology, The University of Yaoundé I, Yaoundé, Cameroon., Mikangue CAM; Department of Microbiology, The University of Yaoundé I, Yaoundé, Cameroon., Membangbi AE; Department of Microbiology, The University of Yaoundé I, Yaoundé, Cameroon., Ngoutane A; Department of Microbiology, The University of Yaoundé I, Yaoundé, Cameroon.; Institute of Medical Research and Medicinal Plant Study, Yaoundé, Cameroon., Elang AF; Department of Microbiology, The University of Yaoundé I, Yaoundé, Cameroon., Touangnou-Chamda SA; Department of Microbiology, The University of Yaoundé I, Yaoundé, Cameroon., Sake CS; Department of Microbiology, The University of Yaoundé I, Yaoundé, Cameroon., Mondinde GI; Faculty of Medicine and Biomedical Sciences, The University of Yaoundé I (Center for the Study and Control of Communicable Diseases (CSCCD), Yaoundé, Cameroon., Kenmoe S; Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon., Essama SHR; Department of Microbiology, The University of Yaoundé I, Yaoundé, Cameroon.

Publikováno v: The Pan African medical journal [Pan Afr Med J] 2022 Oct 11; Vol. 43, pp. 72. Date of Electronic Publication: 2022 Oct 11 (Print Publication: 2022).